RBC Capital Upgrades Intercept Pharmaceuticals (ICPT) to Outperform Following Bullish Doc Survey
Tweet Send to a Friend
(Updated - March 1, 2019 6:34 AM EST) (updated to add analyst comments)RBC Capital analyst Brian Abrahams upgraded Intercept Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
